Zolinza
(Vorinostat)
(100 mg)
(120)
(Tablets)
Zolinza (vorinostat) 100 mg 120 tabs SHARP, Netherlands
Article:
Indications:
- Treatment of cutaneous T-cell lymphoma, progressive properties of persistence or recurrence despite ongoing systemic chemotherapy.
Dosage and administration
- Apply inside. The drug should be taken with food. The recommended dose is 400 mg (4 capsules) once a day. If necessary, the dose can be reduced to 300 mg (3 capsules) once a day, and the dosage regimen can be reduced, if necessary, up to 5 consecutive days per week.
- Treatment is continued until there is no evidence of disease progression or until symptoms of toxicity appear.
- Dose adjustment for elderly patients is not necessary.
-
Commercial name:Zolinza
-
Сhemical name:Vorinostat
-
Dosage:100 mg
-
Quantity:120
-
Release form:Tablets
-
Виробник:MSD, Великобритания
No reviews yet